SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma.
Kottschade LA, Pond GR, Olszanski AJ, Zakharia Y, Domingo-Musibay E, Hauke RJ, Curti BD, Schober S, Milhem MM, Block MS, Hieken T, McWilliams RR.
Kottschade LA, et al. Among authors: domingo musibay e.
Clin Cancer Res. 2023 Jun 13;29(12):2220-2225. doi: 10.1158/1078-0432.CCR-22-3207.
Clin Cancer Res. 2023.
PMID: 37000165